General Session: The $1,000 Genome: Impact on Science and Society
Kevin Davies, PhD, MA

 

In the decade since the completion of the Human Genome Project, the worlds of science and medicine have experienced profound change. The cost of sequencing a genome has plummeted from hundreds of millions of dollars to barely $1,000, while what once took years can now be done in about a day. Genome sequencing is now routinely applied in medicine and clinical trials, particularly in oncology. And the President has proposed a new Precision Medicine Initiative to build a biobank of 1 million volunteers. Kevin Davies, the founding editor of Nature Genetics and author of "The $1,000 Genome", will discuss the legacy of the Human Genome Project, the breakthrough technologies that have brought us to the brink of the $1,000 genome, the impact of clinical and consumer genetics, and v the legal and societal complications of what many view as the erosion of genomic privacy.